Grifols SaGrifols SaGrifols Sa

Grifols Sa

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪7.42 B‬USD
‪65.47 M‬USD
‪7.28 B‬USD
‪291.12 M‬
Beta (1Y)
1.35
Employees (FY)
‪23.74 K‬
Change (1Y)
‪−2.58 K‬ −9.81%
Revenue / Employee (1Y)
‪306.43 K‬USD
Net income / Employee (1Y)
‪2.76 K‬USD

About GRIFOLS S.A.


CEO
Nacho Abia
Headquarters
Barcelona
Founded
1940
ISIN
ES0171996087
FIGI
BBG000PS7RC0
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
GRFS5271380
Grifols Escrow Issuer SA 4.75% 15-OCT-2028
Yield to maturity
6.55%
Maturity date
Oct 15, 2028
XS239300189
GRIFOLS S.A. 21/28 REGS
Yield to maturity
4.84%
Maturity date
Oct 15, 2028
XS207764639
GRIFOLS 19/27 REGS
Yield to maturity
3.11%
Maturity date
Nov 15, 2027
XS207683655
GRIFOLS 19/25 REGS
Yield to maturity
2.23%
Maturity date
Feb 15, 2025

Explore more bonds 

Frequently Asked Questions


The current price of GIFLF is 11.39 USD — it has increased by 0.26% in the past 24 hours. Watch Grifols Sa stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Grifols Sa stocks are traded under the ticker GIFLF.
GIFLF stock has risen by 0.26% compared to the previous week, the month change is a 1.61% rise, over the last year Grifols Sa has showed a 11.12% increase.
We've gathered analysts' opinions on Grifols Sa future price: according to them, GIFLF price has a max estimate of 28.43 USD and a min estimate of 9.48 USD. Watch GIFLF chart and read a more detailed Grifols Sa stock forecast: see what analysts think of Grifols Sa and suggest that you do with its stocks.
GIFLF reached its all-time high on Jun 20, 2014 with the price of 57.50 USD, and its all-time low was 7.46 USD and was reached on Mar 6, 2024. View more price dynamics on GIFLF chart.
See other stocks reaching their highest and lowest prices.
GIFLF stock is 0.26% volatile and has beta coefficient of 1.35. Track Grifols Sa stock price on the chart and check out the list of the most volatile stocks — is Grifols Sa there?
Today Grifols Sa has the market capitalization of ‪7.96 B‬, it has increased by 4.13% over the last week.
Yes, you can track Grifols Sa financials in yearly and quarterly reports right on TradingView.
Grifols Sa is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
GIFLF earnings for the last quarter are 0.25 USD per share, whereas the estimation was 0.22 USD resulting in a 14.90% surprise. The estimated earnings for the next quarter are 0.20 USD per share. See more details about Grifols Sa earnings.
Grifols Sa revenue for the last quarter amounts to ‪2.00 B‬ USD, despite the estimated figure of ‪1.96 B‬ USD. In the next quarter, revenue is expected to reach ‪1.97 B‬ USD.
GIFLF net income for the last quarter is ‪57.55 M‬ USD, while the quarter before that showed ‪15.90 M‬ USD of net income which accounts for 262.05% change. Track more Grifols Sa financial stats to get the full picture.
Grifols Sa dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 17, 2024, the company has ‪23.74 K‬ employees. See our rating of the largest employees — is Grifols Sa on this list?
Like other stocks, GIFLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Grifols Sa stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Grifols Sa technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Grifols Sa stock shows the sell signal. See more of Grifols Sa technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.